Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2026-02-07 @ 7:24 PM
Study NCT ID:
NCT01405820
Status:
COMPLETED
Last Update Posted:
2015-08-21
First Post:
2011-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-14
First Submit QC Date:
None
Study First Post Date:
2011-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-29
Results First Submit QC Date:
None
Results First Post Date:
2015-07-29
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-03
Last Update Post Date:
2015-08-21
Last Update Post Date Type:
ESTIMATED